Pharmaceutical Antitrust

Venue: Washington

Location: Washington, United States

Event Date/Time: May 24, 2005 End Date/Time: May 25, 2005
Report as Spam


The importance of antitrust concerns to pharmaceutical manufacturers is greater than ever. Heightened scrutiny and increased enforcement activity by federal and state regulators, not to mention legal challenges from competitors and the plaintiffs’ class action bar, have made it vital for companies to carefully consider these complex issues at nearly every stage of a drug’s development and life cycle. Recognizing these issues at the outset and understanding your options is key to ensuring that your company does not endure expensive and time consuming repercussions down the road.

Avoiding these pitfalls requires in-house counsel and attorneys advising the pharmaceutical industry to have an up-to-the-minute and in-depth understanding of the antitrust issues which affect how pharmaceutical companies can conduct their vital businesses. To help you overcome these obstacles, American Conference Institute has developed this conference on Pharmaceutical Antitrust to provide you with the tools you need to develop practical defensive and offensive strategies for dealing with antitrust issues in connection with your pharmaceutical products.